Purchases and Sales Made in Q1 2024 in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY) during Q1 2024. The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-36.9K- 8.98% |
$5.41M - $7.32M
|
374K
$88.3M
|
|
|
May 10, 2024
Q1 2024
|
Mitsubishi Ufj Trust & Banking Corp
Tokyo, M0 |
SELL
|
- |
-37.3K- 10.67% |
$5.46M - $7.39M
|
312K
$73.6M
|
|
|
Dec 06, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-38.2K- 35.15% |
$5.6M - $7.57M
|
70.5K
$16.6M
|
|
|
Apr 25, 2024
Q1 2024
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-38.7K- 4.62% |
$5.67M - $7.67M
|
798K
$188M
|
|
|
Apr 05, 2024
Q1 2024
|
Cwm, LLC
|
SELL
|
- |
-41.7K- 96.03% |
$6.11M - $8.26M
|
1.72K
$406K
|
|
|
Aug 14, 2024
Q1 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-44.9K- 30.35% |
$6.58M - $8.9M
|
103K
$24.3M
|
|
|
May 10, 2024
Q1 2024
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-46.6K- 26.5% |
$6.83M - $9.24M
|
129K
$30.5M
|
|
|
May 15, 2024
Q1 2024
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-59.4K- 35.57% |
$8.71M - $11.8M
|
108K
$25.4M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-66.2K- 8.93% |
$9.7M - $13.1M
|
675K
$159M
|
|
|
May 13, 2024
Q1 2024
|
Fil LTD
Hamilton, D0 |
SELL
|
- |
-66.5K- 86.52% |
$9.74M - $13.2M
|
10.4K
$2.44M
|
|
|
May 14, 2024
Q1 2024
|
Eagle Health Investments LP
Greenwich, CT |
SELL
|
- |
-88.4K- 64.64% |
$13M - $17.5M
|
48.4K
$11.4M
|
|
|
May 13, 2024
Q1 2024
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-89.3K- 29.12% |
$13.1M - $17.7M
|
217K
$51.3M
|
|
|
May 15, 2024
Q1 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-99.1K- 35.65% |
$14.5M - $19.6M
|
179K
$42.2M
|
|
|
May 08, 2024
Q1 2024
|
Bnp Paribas Asset Management Holding S.A.
|
SELL
|
- |
-119K- 94.71% |
$17.4M - $23.5M
|
6.63K
$1.56M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-131K- 16.28% |
$19.2M - $26M
|
675K
$159M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-131K- 16.28% |
$19.2M - $26M
|
675K
$159M
|
|
|
May 14, 2024
Q1 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-132K- 65.72% |
$19.3M - $26.1M
|
68.7K
$16.2M
|
|
|
May 15, 2024
Q1 2024
|
Gilder Gagnon Howe & CO LLC
New York, NY |
SELL
|
- |
-182K- 30.98% |
$26.6M - $36M
|
405K
$95.6M
|
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-183K- 48.44% |
$26.8M - $36.3M
|
195K
$45.9M
|
|
|
May 01, 2024
Q1 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-344K- 4.93% |
$50.3M - $68.1M
|
6.62M
$1.56B
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-415K- 19.18% |
$60.8M - $82.2M
|
1.75M
$412M
|
|
|
May 14, 2024
Q1 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-467K- 89.6% |
$68.4M - $92.5M
|
54.2K
$12.8M
|
|
|
May 15, 2024
Q1 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-553K- 16.15% |
$81M - $110M
|
2.87M
$678M
|
|
|
May 15, 2024
Q1 2024
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-811K- 73.0% |
$119M - $161M
|
300K
$70.8M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.27M- 42.04% |
$186M - $251M
|
1.75M
$412M
|
|
|
May 14, 2024
Q1 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-3.39M- 20.93% |
$496M - $671M
|
12.8M
$3.02B
|